Ketotifen in childhood asthma: a double‐blind placebo controlled trial

Abstract
Summary: In a three week double‐blind cross‐over controlled trial in twenty asthmatic children, ketotifen (HC 20‐511, ‘Zaditen’, Sandoz) showed no significant difference from placebo, although there was a consistent trend in favour of the active drug.

This publication has 4 references indexed in Scilit: